No abstract available
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Agents, Immunological / therapeutic use*
-
CD4-Positive T-Lymphocytes / immunology
-
Carcinoma, Squamous Cell / drug therapy*
-
Carcinoma, Squamous Cell / immunology
-
Carcinoma, Squamous Cell / pathology
-
Carcinoma, Squamous Cell / virology
-
HIV / isolation & purification
-
HIV Infections / complications*
-
HIV Infections / virology
-
Head and Neck Neoplasms / drug therapy*
-
Head and Neck Neoplasms / immunology
-
Head and Neck Neoplasms / pathology
-
Head and Neck Neoplasms / virology
-
Humans
-
Prognosis
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Skin Neoplasms / drug therapy*
-
Skin Neoplasms / immunology
-
Skin Neoplasms / pathology
-
Skin Neoplasms / virology
-
Squamous Cell Carcinoma of Head and Neck / drug therapy*
-
Squamous Cell Carcinoma of Head and Neck / immunology
-
Squamous Cell Carcinoma of Head and Neck / pathology
-
Squamous Cell Carcinoma of Head and Neck / virology
Substances
-
Antineoplastic Agents, Immunological
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor